![Matthew Gall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Gall
Financieel Directeur/CFO bij
TANGO THERAPEUTICS, INC.
Profiel
Matthew Gall is currently Chief Financial Officer at Tango Therapeutics, Inc. since 2026.
Formerly, Mr. Gall was Chief Financial Officer & Treasurer at Kalaris Therapeutics, Inc. from 2025 to 2026, Chief Financial Officer at iTeos Therapeutics, Inc. from 2020 to 2025, and Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
Education includes an undergraduate degree from Bowling Green State University and an MBA from The University of Chicago Booth School of Business.
Actieve functies van Matthew Gall
| Bedrijven | Functie | Begin |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-04-2026 |
Eerdere bekende functies van Matthew Gall
| Bedrijven | Functie | Einde |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Financieel Directeur/CFO | 28-08-2025 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-06-2020 |
Opleiding van Matthew Gall
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Bowling Green State University
 Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
